CWBHF news

Co-founder Jared Stanley resigned from Charlotte's Web's Board of Directors effective June 3, 2026, to focus full-time on his role as CEO of DeFloria, a clinical-stage botanical pharmaceutical company co-founded by Charlotte's Web developing a treatment for autism-related irritability. The move is s…

Charlotte's Web Holdings amended its convertible debenture with BT DE Investments and converted the outstanding principal into common shares effective May 28, 2026. The conversion price was set at $0.94 per share in connection with a $10 million private placement investment.

Charlotte's Web Holdings shareholders voted to approve an amendment to its C$75.3 million convertible debenture held by British American Tobacco and a concurrent equity investment, with 94% voting in favor. The transaction will result in BAT receiving 109.9 million common shares representing 40.6% o…